ÿþ<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"> <html> <head> <meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1"> <title>EASL 2010 - Poster Presentations</title> <link rel="stylesheet" type="text/css" href="style.css"> </head> <body> <table width="750" align="center" border="0" cellspacing="0" cellpadding="0" class="MainTable"> <tr> <td><img src="http://www2.kenes.com/liver-congress/PublishingImages/top_ei.jpg" width="760" height="129" /></td> </tr> <tr> <td class="content"><h1>Poster Presentations</h1> <P><b><u>Apr 15, 2010</u></b></P><p align=right><em>Poster Board Number</em></p><H2>Category 8c. ALCOHOLIC DRUG INDUCED AND FATTY LIVER DISEASE: c. NASH/NAFLD - CLINICAL:<br /></H2><table><tr> <td><a href='Abstract215.htm'><B>IRON STORES, LIVER TRANSAMINASE LEVELS AND METABOLIC RISK IN HEALTHY TEENAGERS</B></a> </em><br> <b>E. Aigner</b><sup>1</sup>*, C. Hinz<sup>1</sup>, K. Steiner<sup>2</sup>, W. Patsch<sup>3</sup>, C. Datz<sup>1</sup><br> <em><sup>1</sup>Department of Internal Medicine, Oberndorf Hospital, Oberndorf, <sup>2</sup>Secondary School for Agriculture and Environmental Technology, Elixhausen, <sup>3</sup>Paracelsus Medical University, Salzburg, Austria. *e.aigner@kh-obdf.salzburg.at</em></td><td valign=top><em>327 </td></tr> <tr> <td><a href='Abstract216.htm'><B>ACETAMINOPHEN METABOLISM: A NOVEL MARKER FOR PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>H.H. A-Kader</b><sup>1</sup>*, M. Merrell<sup>2</sup>, N. Cherringhton<sup>2</sup>, R. Erickson<sup>1</sup><br> <em><sup>1</sup>Pediatrics, <sup>2</sup>Pharmacology, The University of Arizona, Tucson, AZ, USA. *heshamh@aol.com</em></td><td valign=top><em>328 </td></tr> <tr> <td><a href='Abstract217.htm'><B>INFLUENCE OF G308A POLYMORPHISM OF TUMOR NECROSIS FACTOR ALPHA GENE ON HISTOLOGICAL CHANGES OF NON ALCOHOLIC FATTY LIVER DISEASE AND INSULIN RESISTANCE</B></a> </em><br> <b>R. Aller</b><sup>1</sup>*, D. De Luis<sup>2</sup>, O. Izaola<sup>2</sup>, M. González<sup>2</sup>, R. Conde<sup>2</sup>, T. Alvarez<sup>2</sup>, L.I. Fernández<sup>1</sup>, F. Lozano<sup>1</sup>, E. Castro<sup>1</sup>, J.M. González<sup>1</sup>, Departement of Gastroenterology. Hospital Clínico Universitario de Valladolid. Spain.<br> <em><sup>1</sup>Departement of Gastroenterology. Hospital Clínico Universitario de Valladolid. Spain, <sup>2</sup>Universidad de Valladolid, Valladolid, Spain. *roaller@yahoo.es</em></td><td valign=top><em>329 </td></tr> <tr> <td><a href='Abstract218.htm'><B>PREVALENCE AND RISK FACTORS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN RUSSIAN FEDERATION</B></a> </em><br> V. Ivashkin, O. Drapkina, <b>Y. Ashikhmin</b>*<br> <em>I.M.Sechenov Moscow Medical Academy, Moscow, Russia. *megabotan@list.ru</em></td><td valign=top><em>330 </td></tr> <tr> <td><a href='Abstract219.htm'><B>RETINAL VESSEL DIAMETER, </B><B>CAROTID ARTERY IMT</B> <B>AND THE INCIDENCE OF CORONARY ARTERY DISEASE IN PATIENTS WITH NAFLD</B></a> </em><br> A. Ibrahim<sup>1</sup>, S. Abo Mouch<sup>2</sup>, A. Marmor<sup>3</sup>, A. Djibre<sup>4</sup>, <b>N. Assy</b><sup>4,5</sup>*<br> <em><sup>1</sup>Ophtalmology, Ziv Medical Centre, Safed, <sup>2</sup>Liver Unit, Hille Yafe Hospital, Hadera, <sup>3</sup>Cardiology, <sup>4</sup>Liver Unit, Ziv Medical Centre, Safed, <sup>5</sup>Faculty of Medicine, Technion Institute, Haifa, Israel. *assy.n@ziv.health.gov.il</em></td><td valign=top><em>331 </td></tr> <tr> <td><a href='Abstract220.htm'><B>PEROXIDIZED FATTY ACIDS MAY INDUCE A PRO-INFLAMMATORY RESPONSE IN THE LIVER AND MAY TRIGGER THE OUTBREAK OF NON-ALCOHOLIC STEATOHEPATITIS</B> <B>(NASH)</B></a> </em><br> <b>T. Boehm</b><sup>1</sup>*, S. Sagmeister<sup>1</sup>, H. Berger<sup>1</sup>, A. Daryabeigi<sup>1</sup>, E. Haslinger<sup>1</sup>, M. Murkovic<sup>2</sup>, N. Rohr-Udilova<sup>3</sup>, K. Stolze<sup>4</sup>, W. Huber<sup>1</sup>, B. Grasl-Kraupp<sup>1</sup><br> <em><sup>1</sup>Res. Unit Chemical Safety and Cancer Prevention, Inst. of Cancer Research,CIM1, University of Vienna, Vienna, <sup>2</sup>Institute for Food Chemistry and Technology, University of Technology, Graz, <sup>3</sup>Dept of Gastroenterology, CIM3, Med. Univ. Vienna, Austria, <sup>4</sup>Dept. Natural Sciences, Univ. of Veterinary Medicine, Vienna, Austria. *therese_boehm@gmx.at</em></td><td valign=top><em>332 </td></tr> <tr> <td><a href='Abstract221.htm'><B>POLYUNSATURATED FATTY ACID COMPOSITION IN ERYTHROCYTE LIPID MEMBRANES IN NASH: UNEXPECTED HETEROGENEITY IN THE N6-N3 RATIO</B></a> </em><br> <b>S. Caldwell</b>*, C. Argo, A. Al-Osaimi, N. Shah, H. Lothamer, C. Harmon, J. Rodriguez<br> <em>University of Virginia, Charlottesville, VA, USA. *shc5c@virginia.edu</em></td><td valign=top><em>333 </td></tr> <tr> <td><a href='Abstract222.htm'><B>NON-INVASIVE DIAGNOSIS OF LIVER LESIONS BY BLOOD TESTS IN NAFLD</B></a> </em><br> <b>P. Calès</b><sup>1</sup>*, J. Boursier<sup>1</sup>, J. Chaigneau<sup>1</sup>, V. Roullier<sup>2</sup>, F. Lainé<sup>3</sup>, J. Sandrini<sup>1</sup>, S. Michalak<sup>1</sup>, I. Hubert<sup>1</sup>, N. Dib<sup>1</sup>, F. Oberti<sup>1</sup>, S. Bertrais<sup>4</sup>, G. Hunault<sup>4</sup>, M.C. Rousselet<sup>1</sup>, C. Cavaro-Ménard<sup>2</sup>, Y. Gallois<sup>1</sup>, Y. Deugnier<sup>3</sup><br> <em><sup>1</sup>CHU, <sup>2</sup>Laboratoire LISA, Angers, <sup>3</sup>CHU, Rennes, <sup>4</sup>Laboratoire HIFIH, Angers, France. *paul.cales@unvi-angers.fr</em></td><td valign=top><em>334 </td></tr> <tr> <td><a href='Abstract223.htm'><B>LIVER GENIC EXPRESSION PROFILE DURING THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN MORBID OBESITY PATIENTS</B></a> </em><br> <b>A. Carazo</b><sup>1</sup>*, J. León<sup>1,2</sup>, J. Casado<sup>1</sup>, A. Gila<sup>1,2</sup>, A. Martín<sup>1</sup>, L. Sanjuan<sup>1</sup>, S. Delgado<sup>3</sup>, T. Caballero<sup>2,4</sup>, J.L. Mundi<sup>1</sup>, J. Salmerón<sup>1,2</sup><br> <em><sup>1</sup>Unidad de Aparato Digestivo, Hospital Universitario San Cecilio, <sup>2</sup>Ciber de Enfermedades Hepáticas Digestivas, <sup>3</sup>Unidad de Cirugía, Hospital Universitario San Cecilio, <sup>4</sup>Departamento de Anatomía Patológica, Universidad de Granada, Granada, Spain. *angel_carazo@yahoo.es</em></td><td valign=top><em>335 </td></tr> <tr> <td><a href='Abstract224.htm'><B>HYPERHOMOCYSTEINEMIA AND C677T METHYLENETETRAHIDROFOLATE REDUCTASE GENE POLYMORPHISMS IN SPANISH PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>J.A. Chirinos Vega</b><sup>1</sup>*, M. Perez Carreras<sup>1</sup>, C. Fernández-Miranda<sup>2</sup>, G. López-Alonso<sup>3</sup>, R. Ayala<sup>4</sup>, C. Arribas<sup>1</sup>, G. Castellano<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, <sup>2</sup>Internal Medicine, <sup>3</sup>Pathology, <sup>4</sup>Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain. *juanochirinos@hotmail.com</em></td><td valign=top><em>336 </td></tr> <tr> <td><a href='Abstract225.htm'><B>NON ALCOHOLIC FATTY LIVER DISEASE AND AGING. PREVALENCE AND ASSOCIATED FACTORS</B></a> </em><br> G. Bianchi<sup>1</sup>, G. Bertaccini<sup>1</sup>, G. Marchesini<sup>2</sup>, <b>C. Conte</b><sup>1</sup>*, R. Chianese<sup>1</sup>, M. Zoli<sup>1</sup><br> <em><sup>1</sup>Medicina Interna, dell'Invecchiamento e Malattie Nefrologiche, <sup>2</sup>Medicina Clinica, Alma Mater Studiorum, Universitá di Bologna, Bologna, Italy. *camilla.conte@yahoo.it</em></td><td valign=top><em>337 </td></tr> <tr> <td><a href='Abstract226.htm'><B>RISK OF EARLY ATHEROSCLEROSIS BY CAROTID ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE AND LOW VISCERAL ADIPOSITY</B></a> </em><br> <b>A.L. Fracanzani</b>*, M. Porzio, L. Burdick, C. Bertelli, L. Valenti, D. Bignamini, E. Fatta, C. Masetti, S. Fargion<br> <em>Internal Medicine, Maggiore Policlinico Hospital Foundation IRCCS, University of Milan, Milano, Italy. *anna.fracanzani@unimi.it</em></td><td valign=top><em>338 </td></tr> <tr> <td><a href='Abstract227.htm'><B>NAFLD LIVER FAT SCORE STRONGLY CORRELATES WITH HISTOLOGICAL SEVERITY OF NAFLD AND NASH IN A LARGE COHORT OF PROSPECTIVELY INCLUDED OVERWEIGHT PATIENTS</B></a> </em><br> <b>S. Francque</b><sup>1</sup>*, A. Verrijken<sup>2</sup>, I. Mertens<sup>2</sup>, G. Hubens<sup>3</sup>, E. Van Marck<sup>4</sup>, P. Michielsen<sup>1</sup>, L. Van Gaal<sup>2</sup><br> <em><sup>1</sup>Department of Gastroenterology Hepatology, <sup>2</sup>Department of Endocrinology, Diabetology and Metabolism, <sup>3</sup>Department of Abdominal Surgery, <sup>4</sup>Department of Pathology, Antwerp University Hospital, Edegem, Belgium. *sven.francque@uza.be</em></td><td valign=top><em>339 </td></tr> <tr> <td><a href='Abstract228.htm'><B>FATTY LIVER INDEX (FLI) IS AN INDEPENDENT PREDICTOR OF CHANGES IN METABOLIC AND CARDIOVASCULAR PARAMETERS: RESULTS FROM A 3-YEAR FOLLOW UP IN THE RISC STUDY</B></a> </em><br> <b>A. Gastaldelli</b><sup>1</sup>*, M. Kozakova<sup>2</sup>, E. Buzzigoli<sup>1</sup>, R. Petz<sup>1</sup>, B. Balkau<sup>3,4</sup>, RISC Investigators<br> <em><sup>1</sup>Stable Isotope Laboratory, Institute Clinical Physiology-CNR, <sup>2</sup>Dpt. of Internal Medicine, University of Pisa, Pisa, Italy, <sup>3</sup>INSERM U780, Villejuif, <sup>4</sup>University Paris Sud, Orsay, France. *amalia@ifc.cnr.it</em></td><td valign=top><em>340 </td></tr> <tr> <td><a href='Abstract229.htm'><B>PREVALENCE OF TRANSAMINASE ABNORMALITIES </B><B>IN GENERAL POPULATION IN XXI CENTURY: THE BAGNACAVALLO STUDY</B></a> </em><br> <b>P. Giacomoni</b><sup>1</sup>*, F.G. Foschi<sup>2</sup>, M. Domenicali<sup>3</sup>, S. Savini<sup>2</sup>, F. Dazzani<sup>1</sup>, A.C. Dall'Aglio<sup>3</sup>, G. Saini<sup>4</sup>, G. Re<sup>1</sup>, T. Casetti<sup>4</sup>, P. Andreone<sup>3</sup>, M. Bernardi<sup>3</sup>, G.F. Stefanini<sup>2</sup><br> <em><sup>1</sup>Ospedale di Lugo, AUSL di Ravenna, Lugo, <sup>2</sup>Ospedale di Faenza, AUSL di Ravenna, Faenza, <sup>3</sup>Clinica Medica, Università di Bologna, Bologna, <sup>4</sup>Ospedale di Ravenna, AUSL di Ravenna, Ravenna, Italy. *p.giacomoni@ausl.ra.it</em></td><td valign=top><em>341 </td></tr> <tr> <td><a href='Abstract230.htm'><B>A PROSPECTIVE EVALUATION OF HISTOLOGIC CHANGES IN NON-ALCOHOLIC FATTY LIVER DISEASE </B></a> </em><br> N.G. Unal<sup>1</sup>, F. Yilmaz<sup>2</sup>, <b>F. Gunsar</b><sup>1</sup>*, D. Nart<sup>2</sup>, R. Vardar<sup>1</sup>, Z. Karasu<sup>1</sup>, G. Ersoz<sup>1</sup>, U.S. Akarca<sup>1</sup><br> <em><sup>1</sup>Gastroenterology Department, <sup>2</sup>Pathology Department, Ege University Medical School, Izmir, Turkey. *fgunsar@yahoo.com</em></td><td valign=top><em>342 </td></tr> <tr> <td><a href='Abstract231.htm'><B>THE EFFICACY OF LICORICE ROOT EXTRACT IN DECREASING TRANSAMINASE</B> <B>ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>A.A. Haji Agha Mohammadi</b><sup>1,2</sup>*, J. Shokri Shirvani<sup>3</sup>, M. Jabbari<sup>4</sup><br> <em><sup>1</sup>Qazvin University of Medical Science, <sup>2</sup>Qazvin Metabolic Disease Research Center, Qazvin, <sup>3</sup>Babol University of Medical Sciences, Babol, <sup>4</sup>Statistical Consultant, Qazvin, Iran. *ahmohamadi@qums.ac.ir</em></td><td valign=top><em>343 </td></tr> <tr> <td><a href='Abstract232.htm'><B>ELEVATED LEVELS OF FETUIN A IN NONALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>J.W. Haukeland</b><sup>1,2</sup>*, Z. Konopski<sup>1</sup>, E. Aasheim<sup>1</sup>, O.E. Johansen<sup>3</sup>, E.M. Løberg<sup>4</sup>, T. Haaland<sup>4</sup>, I. Gladhaug<sup>2,5</sup>, T. Dahl<sup>6</sup>, A. Yndestad<sup>6</sup>, P. Aukrust<sup>2,6</sup>, B. Halvorsen<sup>2,6</sup>, K.I. Birkeland<sup>1,2</sup><br> <em><sup>1</sup>Medical Department, Oslo University Hospital Aker, <sup>2</sup>Faculty of Medicine, University of Oslo, <sup>3</sup>Medical Department, Asker and Bærum Hospital Vestre Viken, <sup>4</sup>Department of Pathology, Oslo University Hospital Ullevål, <sup>5</sup>Department of Surgery, <sup>6</sup>Research Institute for Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. *j.w.haukeland@medisin.uio.no</em></td><td valign=top><em>344 </td></tr> <tr> <td><a href='Abstract233.htm'><B>DIAGNOSTIC VALUE OF LIVER INJURY BIOMARKERS, FIBROTEST (FT), STEATOTEST (ST), NASHTEST (NT) IN PATIENTS WITHOUT ADVANCED DISEASE UNDERGOING BARIATRIC SURGERY</B></a> </em><br> <b>A. Hollebecque</b><sup>1</sup>*, M. Munteanu<sup>2</sup>, L. Arnalsteen<sup>3</sup>, D. Buob<sup>4</sup>, E. Leteurtre<sup>4</sup>, R. Caiazzo<sup>3</sup>, S. Dharancy<sup>1</sup>, T. Poynard<sup>5</sup>, V. Ratziu<sup>5</sup>, F. Pattou<sup>3</sup>, P. Mathurin<sup>1</sup><br> <em><sup>1</sup>Maladies de l'Appareil Digestif, Hôpital Huriez, Lille, <sup>2</sup>Société BioPredictive, Paris, <sup>3</sup>Service de Chirurgie Digestive et Endocrinienne, Hôpital Huriez, <sup>4</sup>Service d'Anatomie Pathologique, CHU de Lille, Lille, <sup>5</sup>Service d'Hépato-Gastroentérologie, Hôpital de la Pitié-Salpétrière, Paris, France. *philippe.mathurin@chru-lille.fr</em></td><td valign=top><em>345 </td></tr> <tr> <td><a href='Abstract234.htm'><B>EXCESSIVE VISCERAL FAT ACCUMULATION PLAYS BOTH ROLES AS THE FIRST AND SECOND HIT IN THE PATHOGENESIS AND PROGRESSION OF NONALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>E. Ishibashi</b><sup>1,2</sup>*, Y. Eguchi<sup>2</sup>, T. Mizuta<sup>2</sup>, Y. Kitajima<sup>1,2</sup>, Y. Kawaguchi<sup>2</sup>, T. Kuwashiro<sup>2</sup>, S. Matsunaga<sup>3</sup>, Y. Oda<sup>4</sup>, I. Ozaki<sup>2</sup>, K. Anzai<sup>2</sup>, R. Iwakiri<sup>2</sup>, N. Ono<sup>1</sup>, T. Eguchi<sup>1</sup>, S. Koizumi<sup>3</sup>, K. Fujimoto<sup>2</sup><br> <em><sup>1</sup>Clinical Gastroenterology, Eguchi Hospital, Ogi, <sup>2</sup>Internal Medicine, <sup>3</sup>General Medicine, <sup>4</sup>Education and Research Center for Comprehensive Community Medicine, Saga Medical School, Saga, Japan. *eguchiyu@med.saga-u.ac.jp</em></td><td valign=top><em>346 </td></tr> <tr> <td><a href='Abstract235.htm'><B>NONINVASIVE LABORATORY TESTS DESIGNED FOR EVALUATE FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C ARE USEFUL IN NON ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>C. Ivantes</b><sup>1,2</sup>*, R. Nones<sup>2</sup>, A. Pissaia Jr<sup>2</sup>, M. Godoy<sup>1</sup>, T. Furlan<sup>1</sup>, V. Menegassi<sup>1</sup>, R. Guzela<sup>1</sup>, M.L. Pedroso<sup>1</sup><br> <em><sup>1</sup>Internal Medicine - Gastroenterology, HC - UFPR, <sup>2</sup>Gastroenterology Service, Hospital Nossa Senhora das Graças, Curitiba, Brazil. *civantes@uol.com.br</em></td><td valign=top><em>347 </td></tr> <tr> <td><a href='Abstract236.htm'><B>IS POSTPRANDIAL INSULIN A USEFUL SCREENING TOOL FOR INSULIN RESISTANCE : AND ITS COMPARISON WITH HOMA IN PATIENTS WITH NAFLD</B></a> </em><br> <b>A.K. Jain</b><sup>1</sup>*, A. Namdeo<sup>1</sup>, S. Jain<sup>2</sup>, S. Sircar<sup>1</sup>, G.G. Joshi<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, <sup>2</sup>Radiodiagnosis, Choithram Hospital and Research Centre, Indore, India. *ajayvjain@yahoo.com</em></td><td valign=top><em>348 </td></tr> <tr> <td><a href='Abstract237.htm'><B>NON-ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY CALCIFICATION SCORE BY MULTI-DETECTOR COMPUTED TOMOGRAPHY; CROSS-SECTIONAL CASE-CONTROL STUDY FROM HEALTHCARE CENTERS' NETWORK</B></a> </em><br> <b>D. Kim</b><sup>1</sup>*, E.H. Park<sup>2</sup>, W. Kim<sup>3</sup>, S.-Y. Choi<sup>1</sup>, Y.J. Kim<sup>4</sup>, J.-H. Yoon<sup>4</sup>, S.-H. Cho<sup>1</sup>, H.-S. Lee<sup>4</sup><br> <em><sup>1</sup>Department of Internal Medicine, Seoul National University Hospital, Gangnam Healthcare Center, <sup>2</sup>Department of Internal Medicine, Seoul National University Bundang Hospital, <sup>3</sup>Department of Internal Medicine, Seoul National University Boramae Hospital, <sup>4</sup>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. *messmd@chol.com</em></td><td valign=top><em>349 </td></tr> <tr> <td><a href='Abstract238.htm'><B>PREVALENCE OF PREVIOUSLY UNRECOGNIZED AND ASYMPTOMATIC NAFLD AMONG PATIENTS WITH METABOLIC RISK FACTORS</B></a> </em><br> <b>T. Koller</b>*, J. Kollerova, T. Hlavaty, M. Huorka, E. Kresanova, J. Payer<br> <em>V. Interna Klinika LFUK, FNsP Bratislava, Comenius University Medical School, Bratislava, Slovak Republic. *koller.tomas@gmail.com</em></td><td valign=top><em>350 </td></tr> <tr> <td><a href='Abstract239.htm'><B>SIMVASTATIN</B><B> AND URSODEOXYCHOLIC ACID IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME </B></a> </em><br> <b>O.N. Korneeva</b>*, O.M. Drapkina, V.T. Ivashkin<br> <em>Internal Disease, I.M.Sechenov Moscow Medical Academy, Moscow, Russia. *doctorok@land.ru</em></td><td valign=top><em>351 </td></tr> <tr> <td><a href='Abstract240.htm'><B>THIAZOLIDINEDIONES (TZDS) FOR NONALCOHOLIC STEATOHEPATITIS (NASH). A META-ANALYSIS</B></a> </em><br> C. Triantos<sup>1</sup>, <b>N. Koukias</b><sup>1</sup>*, A. Tsamandas<sup>1</sup>, V. Nikolopoulou<sup>1</sup>, A.K. Burroughs<sup>2</sup><br> <em><sup>1</sup>University Hospital of Patras, Patras, Greece, <sup>2</sup>Royal Free Hospital, London, UK. *nimkouk@hotmail.com</em></td><td valign=top><em>352 </td></tr> <tr> <td><a href='Abstract241.htm'><B>ADIPOKINES AND CYTOKINE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): A CASE CONTROL STUDY</B></a> </em><br> <b>R. Kumar</b>*, K. Madan, S. Prakash, S. Khanal, S.D. Gupta, S.K. Acharya<br> <em>All India Institute of Medical Science, New Delhi, India. *drramesh1977@yahoo.com</em></td><td valign=top><em>353 </td></tr> <tr> <td><a href='Abstract242.htm'><B>THE ROLE OF DISTANT MARKERS OF FIBROSIS AND NONSPECIFIC INFLAMMATION IN DEVELOPMENT OF NON- ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>O. Lavrynenko</b>*, L. Zhuravlyova, V. Khvorostynka<br> <em>Kharkiv National Medical University, Kharkiv, Ukraine. *olavrynenko@mail.ru</em></td><td valign=top><em>354 </td></tr> <tr> <td><a href='Abstract243.htm'><B>IS OIL RED-O AND DIGITAL IMAGE ANALYSIS THE GOLD STANDARD FOR QUANTIFYING STEATOSIS IN THE LIVER?</B></a> </em><br> <b>A.P. Levene</b><sup>1</sup>*, H. Kudo<sup>1</sup>, M.R. Thursz<sup>2</sup>, Q.M. Anstee<sup>2</sup>, R.D. Goldin<sup>1</sup><br> <em><sup>1</sup>Histopathology, <sup>2</sup>Gastroenterology & Hepatology, Imperial College Faculty of Medicine at St Mary's Hospital, London, UK. *adamlevene@doctors.org.uk</em></td><td valign=top><em>355 </td></tr> <tr> <td><a href='Abstract244.htm'><B>ENHANCED EXPRESSION OF LIVER X RECEPTOR AND ITS LIPOGENIC AND INFLAMMATORY TARGETS IN NONALCOHOLIC FATTY LIVER DISEASE AND CHRONIC HEPATITIS C</B></a> </em><br> <b>E. Lima</b><sup>1</sup>*, M.V. García-Mediavilla<sup>1,2</sup>, M.E. Miquilena-Colina<sup>2,3</sup>, J. Vargas-Castrillón<sup>2,3</sup>, T. Lozano-Rodríguez<sup>2,3</sup>, M. Fernández-Bermejo<sup>4</sup>, J.L. Olcoz<sup>5</sup>, J. González-Gallego<sup>1,2</sup>, C. García-Monzón<sup>2,3</sup>, S. Sánchez-Campos<sup>1,2</sup><br> <em><sup>1</sup>Institute of Biomedicine (IBIOMED), University of León, León, <sup>2</sup>Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd) del Instituto Carlos III, <sup>3</sup>Liver Research Unit, Universitary Hospital Santa Cristina, Madrid, <sup>4</sup>Gastroenterology Service, San Pedro de Alcántara Hospital, Cáceres, <sup>5</sup>Department of Gastroenterology, Complejo Asistencial de León, León, Spain. *elimc@unileon.es</em></td><td valign=top><em>356 </td></tr> <tr> <td><a href='Abstract245.htm'><B>NAFLD FIBROSIS SCORE IS NOT ACCURATE TO IDENTIFY ADVANCED FIBROSIS IN MORBID OBESITY</B></a> </em><br> <b>M.V. Machado</b><sup>1</sup>*, J. Coutinho<sup>2</sup>, F. Carepa<sup>2</sup>, A. Costa<sup>3</sup>, H. Cortez-Pinto<sup>1</sup><br> <em><sup>1</sup>Gastrenterologia e Hepatologia, <sup>2</sup>Cirurgia, <sup>3</sup>Anatomia Patológica, Hospital de Santa Maria, Lisbon, Portugal. *mverdelhomachado@gmail.com</em></td><td valign=top><em>357 </td></tr> <tr> <td><a href='Abstract246.htm'><B>IN MORBID OBESITY, NONALCOHOLIC FATTY LIVER DISEASE ASSSOCIATES TO FAT OVERLOAD IN THE MUSCLE BUT NOT MUSCLE MITOCHONDRIAL DYSFUNCTION</B></a> </em><br> <b>M.V. Machado</b><sup>1</sup>*, A.R. Silvestre<sup>2</sup>, T. Evangelista<sup>2</sup>, J. Coutinho<sup>3</sup>, F. Carepa<sup>3</sup>, A. Costa<sup>4</sup>, H. Cortez-Pinto<sup>1</sup><br> <em><sup>1</sup>Gastrenterologia e Hepatologia, <sup>2</sup>Neuropatologia, <sup>3</sup>Cirurgia, <sup>4</sup>Anatomia Patológica, Hospital de Santa Maria, Lisbon, Portugal. *mverdelhomachado@gmail.com</em></td><td valign=top><em>358 </td></tr> <tr> <td><a href='Abstract247.htm'><B>SURROGATE MARKERS OF INSULIN SENSITIVITY / RESISTANCE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASES AND CHRONIC HEPATITIS C</B></a> </em><br> <b>T. Marinova</b><sup>1</sup>*, R. Ivanova<sup>2</sup>, A. Alexiev<sup>1</sup>, A. Ivanova<sup>1</sup>, K. Antonov<sup>1</sup>, D. Jelev<sup>1</sup>, L. Mateva<sup>1</sup><br> <em><sup>1</sup>Clinic of Gastroenterology, <sup>2</sup>Laboratory of Clinical Pathology, University Hospital 'St. Inav Rilski', Sofia, Bulgaria. *cuci_michonova@abv.bg</em></td><td valign=top><em>359 </td></tr> <tr> <td><a href='Abstract248.htm'><B>ASSOCIATION OF A NON-SYNONYMOUS <I>ABCA1</I> GENE VARIANT WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)</B></a> </em><br> S. Canizales-Quinteros<sup>1</sup>, H. Villamil-Ramirez<sup>1</sup>, F. Sanchez-Munoz<sup>2</sup>, T. Flores-Dorantes<sup>1</sup>, T. Villarreal-Molina<sup>1</sup>, A. Dominguez-Lopez<sup>2</sup>, M. Uribe<sup>3</sup>, <b>N. Mendez-Sanchez</b><sup>3</sup>*<br> <em><sup>1</sup>Molecular Biology and Genomic Medicine Unit, <sup>2</sup>Department of Gastroenterology, National Institute of Nutrition, <sup>3</sup>Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico. *nmendez@medicasur.org.mx</em></td><td valign=top><em>360 </td></tr> <tr> <td><a href='Abstract249.htm'><B>PERFORMANCE OF SIMPLE ALGORITHM TESTS FOR THE DETECTION OF FIBROSIS IN NALFD</B></a> </em><br> <b>M. Miller</b>*, H. Jafferbhoy, S. Walsh, J.F. Dillon<br> <em>Biomedical Research Institute, University of Dundee, Dundee, UK. *m.miller@dundee.ac.uk</em></td><td valign=top><em>361 </td></tr> <tr> <td><a href='Abstract250.htm'><B><SUP>13</SUP>C BREATH TEST IDENTIFIES DECREASED BETA-OXIDATION, IMPROVED GLUCOSE TOLERANCE AND HEPATIC IMPAIRMENT IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS AFTER AN EXERCISE AND DIET INTERVENTION</B></a> </em><br> <b>M. Mizrahi</b><sup>1</sup>*, G. Lalazar<sup>2</sup>, T. Adar<sup>1</sup>, Y. Ilan<sup>1</sup><br> <em><sup>1</sup>Liver Unit Hadassah Ein Karem Medical Center, Hebrew University, <sup>2</sup>Liver Unit Hadassah Ein Karem Medical Center, Jerusalem, Israel. *mizrahim@hadassah.org.il</em></td><td valign=top><em>362 </td></tr> <tr> <td><a href='Abstract251.htm'><B>ASSOCIATION BETWEEN EXCESSIVE SOFT DRINK CONSUMPTION, NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD), AND CORONARY ARTERY DISEASE</B></a> </em><br> <b>F. Nassar</b><sup>1</sup>*, A. Djibre<sup>2</sup>, A. Marmor<sup>3</sup>, N. Assy<sup>2,4</sup><br> <em><sup>1</sup>Internal Medicine, Western Galilee Hospital, Naharyia, <sup>2</sup>Liver Unit, <sup>3</sup>Cardiology, Ziv Medical Centre, Safed, <sup>4</sup>Faculty of Medicine, Technion Institute, Haifa, Israel. *assy.n@ziv.health.gov.il</em></td><td valign=top><em>363 </td></tr> <tr> <td><a href='Abstract252.htm'><B>HYPOTHYROIDISM AND GLUCOSE HOMEOSTASIS MARKERS IN NAFLD PATIENTS</B></a> </em><br> <b>C.P. Oliveira</b>*, V.M. Lima, F. Rabelo, J.T. Stefano, J. Faintuch, D.C. Mazo, M.A. Nogueira, M. Cunha-Silva, R.G. De Lima, F.J. Carrilho<br> <em>Gastroenterology, University of São Paulo School of Medicine, São Paulo, Brazil. *cpm@usp.br</em></td><td valign=top><em>364 </td></tr> <tr> <td><a href='Abstract253.htm'><B>IS TYPE OF STEATOHEPATITES INFLUENCE THE CARDIOVASCULAR AND DIABETUS MELLITUL RISK PROFILE? </B></a> </em><br> <b>A. Peltec</b><sup>1</sup>*, V. Ivanov<sup>2</sup>, A. Pereteatco<sup>3</sup>, L. Calin<sup>4</sup>, V. Dumbrava<sup>1</sup><br> <em><sup>1</sup>Internal Medicine Nb 4, University of Medicine and Pharmacy  Nicolae Testemitanu , <sup>2</sup>Cardiomyopathy and Myocarditis, Institute of Cardiology, <sup>3</sup>Cardiology, Central Railways Hospital, <sup>4</sup>Functional Diagnostic, Institute of Cardiology, Chishinev, Moldova. *apeltec@yahoo.com</em></td><td valign=top><em>365 </td></tr> <tr> <td><a href='Abstract254.htm'><B>THE IMPACT AND THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE ON CHRONIC HEPATITIS B</B></a> </em><br> <b>I. Pirvulescu</b>*, L. Gheorghe, S. Suciu, C. Gheorghe, M. Diculescu<br> <em>Fundeni Clinical Institute of Digestive Diseases and Liver Transplantation, Bucharest, Romania. *iulianapirvulescu@yahoo.com</em></td><td valign=top><em>366 </td></tr> <tr> <td><a href='Abstract255.htm'><B>THE ROLE OF NAFDL IN CARDIOVASCULAR DISEASE</B></a> </em><br> <b>E.C. Rezi</b><sup>1</sup>*, M. Strugariu<sup>2</sup>, R. Mihaila<sup>3</sup><br> <em><sup>1</sup>Second Medical Department, Emergency Clinical County Hospital, Sibiu, <sup>2</sup>Diabetes and Nutrtion Diseases Department, Emergency Clinical County Hospital, SIBIU, <sup>3</sup>Mediac Faculty, Lucian Blaga University Sibiu, Sibiu, Romania. *crimuntean@yahoo.com</em></td><td valign=top><em>367 </td></tr> <tr> <td><a href='Abstract256.htm'><B>THE FATTY LIVER IN NON OBESE CITIZEN: PRELIMINARY RESULTS FROM A LARGE OSSERVATIONAL STUDY (BAGNACAVALLO STUDY)</B></a> </em><br> <b>G. Saini</b><sup>1</sup>*, F.G. Foschi<sup>1</sup>, P. Giacomoni<sup>2</sup>, M. Domenicali<sup>3</sup>, C. Dall'Aglio<sup>1</sup>, S. Savini<sup>1</sup>, F. Dazzani<sup>2</sup>, G. Re<sup>2</sup>, T. Cassetti<sup>4</sup>, P. Andreone<sup>3</sup>, M. Bernardi<sup>3</sup>, F. Stefanini<sup>1</sup>, Ravenna Hepatologic Group<br> <em><sup>1</sup>Dipartimento di Medicina Interna OC di Faenza AUSL di Ravenna, Faenza, <sup>2</sup>Dipartimento di Medicina Interna OC di Lugo AUSL di Ravenna, Ravenna, <sup>3</sup>Medicina Clinica, Università di Bologna, Bologna, <sup>4</sup>Dipartimento delle Malattie Digestive e Metaboliche OC di Ravenna, AUSL di Ravenna, Ravenna, Italy. *gaiasaini@libero.it</em></td><td valign=top><em>368 </td></tr> <tr> <td><a href='Abstract257.htm'><B>A 3-MONTHS INTENSIVE LIFESTYLE INTERVENTION PROGRAM IMPROVED INSULIN RESISTANCE AND REDUCED THE AMOUNT OF STEATOSIS IN PATIENTS WITH NAFLD</B></a> </em><br> <b>F. Scaglioni</b><sup>1</sup>*, M. Marino<sup>1</sup>, M. Malavolti<sup>2</sup>, N.C. Battistini<sup>2</sup>, S. Bellentani<sup>1</sup><br> <em><sup>1</sup>Liver Centre, Azienda USL di Modena, Gastroenterologia Ospedale  Ramazzini , Carpi, <sup>2</sup>Public Health, Sport Centre-University of Modena and Reggio Emilia, Modena, Italy. *federica_scaglioni@yahoo.it</em></td><td valign=top><em>369 </td></tr> <tr> <td><a href='Abstract258.htm'><B>IS ALANINE AMINOTRANSFERASE A SURROGATE MARKER OF SEVERE HEPATOCYTE APOPTOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>H. Senturk</b><sup>1</sup>*, B. Canbakan<sup>1</sup>, M. Canbakan<sup>2</sup>, I. Hatemi<sup>1</sup>, T. Toptas<sup>3</sup>, O. Tabak<sup>4</sup>, H. Balc1<sup>5</sup>, V. Olgac<sup>6</sup>, G. Ozbay<sup>7</sup><br> <em><sup>1</sup>Gastroenterology, Istanbul University, Cerrahpasa Medical Faculty, <sup>2</sup>Nephrology, Haydarpasa Numune Training and Research Hospital, <sup>3</sup>Hematology, Marmara University Medical School, <sup>4</sup>Internal Medicine, Istanbul Education and Training Hospital, <sup>5</sup>Fikret Biyal Central Research Laboratory, Istanbul University, Cerrahpasa Medical Faculty, <sup>6</sup>Institute of Oncology, Istanbul University, Istanbul Medical Faculty, <sup>7</sup>Pathology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey. *drhakansenturk@yahoo.com</em></td><td valign=top><em>370 </td></tr> <tr> <td><a href='Abstract259.htm'><B>PLASMA HOMOCYSTEINE AND METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) <I>C677T </I>POLIMORPHYSM IN BRAZILIAN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> S.R. Carvalho<sup>1</sup>, M.T. Muniz<sup>2</sup>, <b>E.R. Siqueira</b><sup>3</sup>*, K.A. Silva<sup>2</sup>, F.S. Silva<sup>2</sup>, L.C. Bezerra<sup>2</sup>, V.D. Almeida<sup>4</sup>, C.M. Oliveira<sup>3</sup>, L.M. Pereira<sup>1</sup>, São Paulo University and Liver Institute of Pernambuco<br> <em><sup>1</sup>Liver Institute of Pernambuco, <sup>2</sup>Pernambuco University, Recife, <sup>3</sup>São Paulo University, <sup>4</sup>São Paulo Federal University, São Paulo, Brazil. *erfs@usp.br</em></td><td valign=top><em>371 </td></tr> <tr> <td><a href='Abstract260.htm'><B>USEFULNESS OF SERUM HIGH-SENSITIVITY CRP MEASUREMENT IN DIFFERENTIATING NON-ALCOHOLIC STEATOHEPATITIS AND SIMPLE STEATOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>S. Siramolpiwat</b><sup>1</sup>*, C. Pramoolsinsap<sup>1</sup>, N. Wisedopas<sup>2</sup><br> <em><sup>1</sup>Department of Medicine, Ramathibodi Hospital, Mahidol University, <sup>2</sup>Department of Pathology, Chulalongkorn University, Bangkok, Thailand. *sithsira@gmail.com</em></td><td valign=top><em>372 </td></tr> <tr> <td><a href='Abstract261.htm'><B>NOS3-GENE POLYMORPHISM AND ENDOTHELIAL DISFUNCTION IN PATIENTS WITH PORTAL HYPERTENSION</B></a> </em><br> <b>N. Slyvka</b>*<br> <em>Department of Internal Medicine, Clinical Pharmacology, Bukovinian State Medical University, Chernivtsi, Ukraine. *natasha.slivka@mail.ru</em></td><td valign=top><em>373 </td></tr> <tr> <td><a href='Abstract262.htm'><B>MELATONIN IMPROVES MITOCHONDRIAL RESPIRATORY CHAIN ACTIVITY (MRC) AND LIVER HISTOLOGY IN OB/OB MICE</B></a> </em><br> <b>P. Solís-Muñoz</b>*, I. García-Ruiz, E. Gómez-Izquierdo, T. Muñoz-Yagüe, J.A. Solís-Herruzo<br> <em>Research Center, University Hospital '12 de Octubre', Madrid, Spain. *pablo.a.solis@hotmail.com</em></td><td valign=top><em>374 </td></tr> <tr> <td><a href='Abstract263.htm'><B>GLYCEMIC CONTROL PREDICTS FOR LIVER FIBROSIS PROGRESSION IN JAPANESE PATIENTS WITH NAFLD WHO UNDERWENT CONSECUTIVE LIVER BIOPSIES</B></a> </em><br> <b>Y. Takeshita</b><sup>1</sup>*, T. Takamura<sup>1</sup>, E. Hamaguchi<sup>1</sup>, Y. Zen<sup>2</sup>, H. Misu<sup>1</sup>, K. Arai<sup>1</sup>, T. Yamashita<sup>1</sup>, E. Mizukoshi<sup>1</sup>, M. Sasaki<sup>2</sup>, Y. Nakanuma<sup>2</sup>, S. Kaneko<sup>1</sup><br> <em><sup>1</sup>Department of Disease Control and Homeostasis, <sup>2</sup>Department of Human Pathology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan. *takeshita@m-kanazawa.jp</em></td><td valign=top><em>375 </td></tr> <tr> <td><a href='Abstract264.htm'><B>STRONG ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME IN AN URBAN POPULATION OF SIBERIA. RESULTS OF OPEN MULTICENTRAL PROSPECTIVE STUDY DIREG_L_01903</B></a> </em><br> <b>V.V. Tsukanov</b>*, E.V. Lukicheva, J.L. Tonkikh, E.J. Kupershtein, O.S. Amelchugova<br> <em>State Scientific Medical Research Institute for Northern Problems of Siberian Division of Russian Academy of Medical Sciences, Krasnoyarsk, Russia. *rsimpn@scn.ru</em></td><td valign=top><em>376 </td></tr> <tr> <td><a href='Abstract265.htm'><B>BETA-GLOBIN MUTATIONS ARE ASSOCIATED WITH PARENCHYMAL SIDEROSIS AND FIBROSIS SEVERITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE</B></a> </em><br> <b>L. Valenti</b><sup>1</sup>*, E. Canavesi<sup>2</sup>, E. Galmozzi<sup>2</sup>, P. Dongiovanni<sup>2</sup>, R. Rametta<sup>2</sup>, P. Maggioni<sup>2</sup>, A.L. Fracanzani<sup>2</sup>, S. Fargion<sup>2</sup><br> <em><sup>1</sup>Internal Medicine, <sup>2</sup>Università degli Studi di Milano, Milan, Italy. *luca.valenti@unimi.it</em></td><td valign=top><em>377 </td></tr> <tr> <td><a href='Abstract266.htm'><B>HUMAN SERUM METABOLIC PROFILING REVEALS NOVEL BIOMARKERS ASSOCIATED WITH NAFLD PROGRESSION</B></a> </em><br> <b>M. Vazquez-Chantada</b><sup>1</sup>*, J. Barr<sup>1</sup>, C. Alonso<sup>1</sup>, A. Galan<sup>1</sup>, A. Tran<sup>2</sup>, J. Tordjman<sup>3</sup>, Y. Le Marchand-Brustel<sup>4</sup>, P. Gual<sup>4</sup>, M. Martinez-Chantar<sup>5</sup>, S.C. Lu<sup>6</sup>, A. castro<sup>1</sup>, J.M. Mato<sup>5</sup><br> <em><sup>1</sup>OWL Genomics, Bilbao, Spain, <sup>2</sup>Institut National de la Sante et de la Recherche Medicale (INSERM), Nice, <sup>3</sup>INSERM, Paris, <sup>4</sup>INSERM, Nice, France, <sup>5</sup>CIC Biogune, Bilbao, Spain, <sup>6</sup>Division of Gastrointestinal and Liver Diseases, USC, Los Angeles, CA, USA. *mvazquez@owlgenomics.com</em></td><td valign=top><em>378 </td></tr> <tr> <td><a href='Abstract267.htm'><B>QUANTITATIVE ASSESSMENT OF STEATOSIS IN LIVER TRANSPLANTATION BY MORPHOMETRIC ANALYSIS</B></a> </em><br> <b>M. Vertemati</b><sup>1</sup>*, M. Goffredi<sup>2</sup>, P. Aseni<sup>3</sup>, L. Lamperti<sup>2</sup>, M. Cossa<sup>2</sup>, E. Minola<sup>4</sup>, L. De Carlis<sup>3</sup>, L. Vizzotto<sup>2</sup><br> <em><sup>1</sup>Dipartimento di Morfologia Umana e Scienze Biomediche Città Studi, Faculty of Pharmacy, University of Milan, <sup>2</sup>Dipartimento di Morfologia Umana e Scienze Biomediche Città Studi, Faculty of Medicine, University of Milan, <sup>3</sup>Department of Abdominal Organ Transplantation, <sup>4</sup>Department of Pathology, Niguarda Hospital Milan, Milan, Italy. *maurizio.vertemati@unimi.it</em></td><td valign=top><em>379 </td></tr> <tr> <td><a href='Abstract268.htm'><B>LYMPHOCYTES APOPTOSIS IN NASH PATIENTS AND THE EFFECTS OF URSODEOXYCHOLIC ACID</B></a> </em><br> <b>N. Virstyuk</b>*, E. Neyko, V. Neyko, N. Senyutovych<br> <em>Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine. *natalya1727@rambler.ru</em></td><td valign=top><em>380 </td></tr> <tr> <td><a href='Abstract269.htm'><B>DISEASE PROGRESSION OF SIMPLE STEATOSIS AND NONALCOHOLIC STEATOHEPATITIS - A PROSPECTIVE STUDY WITH PAIRED LIVER BIOPSIES 3 YEARS APART</B></a> </em><br> <b>V.W.-S. Wong</b><sup>1</sup>*, G.L.-H. Wong<sup>1</sup>, P.C.-L. Choi<sup>2</sup>, A.W.-H. Chan<sup>2</sup>, M.K.-P. Li<sup>1</sup>, H.-Y. Chan<sup>1</sup>, H.L.-Y. Chan<sup>1</sup><br> <em><sup>1</sup>Department of Medicine and Therapeutics, <sup>2</sup>Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Hong Kong, China. *wongv@cuhk.edu.hk</em></td><td valign=top><em>381 </td></tr> <tr> <td><a href='Abstract270.htm'><B>PROTEIN PATHWAY BIOMARKER SIGNATURE ASSOCIATED WITH SUPERIMPOSED NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND ADVANCED FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C</B></a> </em><br> M. Stepanova<sup>1,2</sup>, D. Limongi<sup>3</sup>, A. Afendy<sup>1,2</sup>, M. Pierobon<sup>3</sup>, I. Younossi<sup>2</sup>, T. Gramlich<sup>4</sup>, L. Liotta<sup>3</sup>, E. Petricoin<sup>3</sup>, <b>Z. Younossi</b><sup>1,2</sup>*<br> <em><sup>1</sup>Betty and Guy Beatty Center for Integrated Research, Inova Health System, <sup>2</sup>Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, <sup>3</sup>Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, <sup>4</sup>AmeriPath, Cleveland, OH, USA. *zobair.younossi@inova.org</em></td><td valign=top><em>382 </td></tr> <tr> <td><a href='Abstract271.htm'><B>A COMPARISON OF FATTY LIVER INDEX WITH THREE NON-INVASIVE METHODS FOR THE DETECTION AND QUANTIFICATION OF LIVER STEATOSIS: REGULAR ULTRASOUND, HEPATORENAL ULTRASOUND INDEX AND STEATOTEST</B></a> </em><br> <b>S. Zelber - Sagi</b><sup>1,2</sup>*, M. Webb<sup>1</sup>, M. Leshno<sup>1</sup>, L. Blendis<sup>1</sup>, H. Yeshua<sup>1</sup>, V. Ratziu<sup>3</sup>, R. Almog<sup>1</sup>, Z. Halpern<sup>1</sup>, R. Oren<sup>1</sup><br> <em><sup>1</sup>Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, <sup>2</sup>School of Public Health, Haifa University, Haifa, Israel, <sup>3</sup>Gastroenterology, Université Pierre et Marie Curie, Hôpital Pitié Salpêtrière, Paris, France. *zelbersagi@bezeqint.net</em></td><td valign=top><em>383 </td></tr> <tr> <td><a href='Abstract272.htm'><B>THE HEPATORENAL ULTRASOUND INDEX IS CORRELATED WITH OBESITY, ALT, INSULIN AND ADIPOCYTOKINES</B></a> </em><br> <b>S. Zelber-Sagi</b><sup>1,2</sup>*, M. Webb<sup>3</sup>, L. Blendis<sup>3</sup>, R. Almog<sup>3</sup>, H. Yeshua<sup>3</sup>, Z. Halpern<sup>3</sup>, R. Oren<sup>3</sup><br> <em><sup>1</sup>Gastroenterology, Tel Aviv Sourasky Medical Center, Tel-Aviv, <sup>2</sup>School of Public Health, Haifa University, Haifa, <sup>3</sup>Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. *zelbersagi@bezeqint.net</em></td><td valign=top><em>384 </td></tr> </table><a href='index.asp'>Back</a><br> <p>&nbsp;</p> <p>&nbsp;</p></td> </tr> </table> </body> </html>